News Articles
Sector/Industry
Please Select
Company
28 October, 2024
PainChek (ASX: PCK) Advances US Expansion with Positive Validation Study Results for FDA Submission
PainChek Limited (ASX: PCK), a leader in digital pain assessment technology, has cleared a significant milestone in its path to US market entry. Following positive results from a validation study,...
24 October, 2024
Aussie Broadband Starts FY25 Strong with Solid Growth Across Segments and New Partnerships
Aussie Broadband (ASX: ABB) has kicked off FY25 with impressive momentum, as outlined in its 1Q trading update released on 25 October 2024. The company reported significant growth in broadband...
24 October, 2024
RocketDNA Gears Up for Expansion with Strong Q3, Secures Key Contracts Across Mining and Law Enforcement
RocketDNA (ASX: RKT) has delivered an action-packed quarterly report for the three months ending September 2024, bolstered by new contracts, sector diversification, and a focus on autonomous drone...
24 October, 2024
Telix Pharmaceuticals' Brain Cancer Imaging Agent Receives Priority Review from FDA
In a significant milestone for Australian biotech, Telix Pharmaceuticals Limited (ASX: TLX) has announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA)...
24 October, 2024
Memphasys’ Felix™ Clinical Trial Nears Completion as CE Mark Strategy Speeds European Market Entry
Australian biotech company Memphasys Limited (ASX: MEM) is closing in on a key milestone with its Felix™ System clinical trial, which is now 90% complete. With fewer than 20 patients left to recruit,...